Reglan: Effective Relief for Gastroparesis and Heartburn
Reglan
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | 0.53 $ | 47.97 $ 47.97 $ (0%) | 🛒 Add to cart |
| 120 | 0.50 $ | 63.96 $ 59.67 $ (7%) | 🛒 Add to cart |
| 180 | 0.46 $ | 95.94 $ 83.07 $ (13%) | 🛒 Add to cart |
| 270 | 0.44 $ | 143.91 $ 119.34 $ (17%) | 🛒 Add to cart |
| 360 | 0.43 $
Best per pill | 191.88 $ 154.44 $ (20%) | 🛒 Add to cart |
Synonyms | |||
Similar products
Reglan (metoclopramide hydrochloride) is a prescription medication designed to accelerate gastric emptying and enhance coordination in the upper gastrointestinal tract. It is primarily indicated for the short-term treatment of diabetic gastroparesis and for the management of gastroesophageal reflux disease (GERD) in patients who have not responded adequately to other therapies. By increasing muscle contractions in the upper digestive system, Reglan helps alleviate symptoms such as nausea, vomiting, persistent heartburn, and the feeling of prolonged fullness after meals. Its prokinetic and antiemetic properties make it a valuable option under careful medical supervision for specific gastrointestinal motility disorders.
Features
- Active ingredient: metoclopramide hydrochloride
- Available in tablet, syrup, and injectable forms
- Functions as a dopamine D2 receptor antagonist
- Enhances acetylcholine release in the myenteric plexus
- Accelerates gastric emptying and improves gastric tone
- Reduces reflux into the esophagus
- Short half-life of approximately 5–6 hours
- FDA-approved for specific gastrointestinal indications
Benefits
- Provides rapid relief from nausea and vomiting associated with gastroparesis
- Reduces symptoms of heartburn and regurgitation in GERD
- Improves overall gastric motility and meal tolerance
- Helps manage diabetic gastroparesis, improving quality of life
- Available in multiple formulations for flexible administration
- Works quickly, often within 30–60 minutes of oral administration
Common use
Reglan is commonly prescribed for the short-term treatment (4–12 weeks) of diabetic gastroparesis, a condition where the stomach empties too slowly due to nerve damage from diabetes. It is also used for symptomatic relief of gastroesophageal reflux disease (GERD) in patients who do not respond to conventional acid-suppressing therapies. In some clinical settings, it may be administered to prevent nausea and vomiting postoperatively or induced by chemotherapy, though these are off-label uses. It is important to note that Reglan is not intended for long-term management due to the risk of serious neurological side effects.
Dosage and direction
For adults with diabetic gastroparesis, the typical oral dosage is 10 mg taken 30 minutes before each meal and at bedtime, not to exceed 40 mg per day. The treatment duration should generally not exceed 12 weeks due to the increased risk of tardive dyskinesia with prolonged use. For GERD, the dosage is often 10–15 mg up to four times daily before meals and at bedtime. The injectable form is administered intramuscularly or intravenously in clinical settings, with dosages adjusted based on patient response and tolerance. Dosage must be individualized, and patients should follow their healthcare provider’s instructions precisely. Use in pediatric populations is limited and requires careful medical oversight.
Precautions
Patients should use Reglan with caution if they have a history of depression, Parkinson’s disease, or hypertension. It may cause drowsiness or dizziness; avoid driving or operating machinery until the effects are known. Regular monitoring for extrapyramidal symptoms is advised, especially with prolonged use. Elderly patients are at higher risk for adverse effects and should receive the lowest effective dose. Alcohol and CNS depressants may enhance sedative effects. Discontinue use immediately if signs of tardive dyskinesia (involuntary movements) appear, as these may be irreversible.
Contraindications
Reglan is contraindicated in patients with gastrointestinal obstruction, perforation, or hemorrhage. It should not be used in those with pheochromocytoma due to the risk of hypertensive crisis. Patients with a history of seizures or epilepsy should avoid Reglan, as it may lower the seizure threshold. Concomitant use with drugs that also prolong the QT interval is not recommended. It is also contraindicated in individuals with known hypersensitivity to metoclopramide or any component of the formulation.
Possible side effect
Common side effects include restlessness, drowsiness, fatigue, and diarrhea. Less frequently, patients may experience extrapyramidal symptoms such as dystonia, akathisia, or parkinsonian-like movements. Rare but serious side effects include tardive dyskinesia (which may be irreversible), neuroleptic malignant syndrome, and depression. Cardiovascular effects like arrhythmias or hypotension may occur, particularly with intravenous administration. Patients should report any unusual or severe symptoms to their healthcare provider promptly.
Drug interaction
Reglan may interact with central nervous system depressants such as alcohol, benzodiazepines, and opioids, increasing sedation. Concurrent use with other dopamine antagonists (e.g., antipsychotics) may enhance extrapyramidal effects. It can affect the absorption of other drugs by altering gastrointestinal motility, such as accelerating the absorption of diazepam or levodopa. Use with caution alongside monoamine oxidase inhibitors (MAOIs) or serotonergic drugs due to potential serotonin syndrome risk. Always inform your prescriber of all medications, including over-the-counter and herbal products.
Missed dose
If a dose is missed, take it as soon as remembered unless it is almost time for the next scheduled dose. Do not double the dose to make up for a missed one. Consistency in timing helps maintain stable symptom control, but irregular dosing may reduce efficacy. If unsure, patients should contact their healthcare provider or pharmacist for guidance.
Overdose
Symptoms of overdose may include drowsiness, disorientation, extrapyramidal reactions, and cardiovascular instability. In severe cases, metoclopramide overdose can lead to seizures or coma. Management is supportive and may include activated charcoal if ingestion was recent, along with symptomatic treatment for neurological or cardiac effects. There is no specific antidote. In case of suspected overdose, seek immediate medical attention or contact a poison control center.
Storage
Store Reglan tablets or syrup at room temperature (15–30°C or 59–86°F), away from light, moisture, and heat. Keep the container tightly closed and out of reach of children and pets. Do not use beyond the expiration date printed on the packaging. For injectable forms, follow specific storage instructions provided by the healthcare facility or manufacturer.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or medication. Do not disregard professional medical advice or delay in seeking it because of something you have read here. Use Reglan only as prescribed by a healthcare professional.
Reviews
Clinical studies and patient reports indicate that Reglan can be highly effective for short-term management of gastroparesis and refractory GERD. Many patients experience significant relief from nausea and improved gastric emptying. However, reviews also highlight concerns about side effects, particularly neurological symptoms like restlessness or involuntary movements with longer use. Medical professionals emphasize that the benefits often outweigh risks when used appropriately under strict supervision for recommended durations. Patient experiences vary, and adherence to prescribed guidelines is critical for safety and efficacy.